Subtopic Deep Dive
Andrographolide Antiviral Properties
Research Guide
What is Andrographolide Antiviral Properties?
Andrographolide antiviral properties refer to the compound's inhibition of viral replication, particularly SARS-CoV-2 main protease, demonstrated through in silico docking and cell-based assays.
Andrographolide from Andrographis paniculata shows antiviral effects against respiratory viruses including SARS-CoV-2. Studies use molecular docking to predict binding to viral proteases and plaque assays in lung epithelial cells. Over 10 papers since 2020 document these findings, with Enmozhi et al. (2020) leading at 397 citations.
Why It Matters
Andrographolide offers leads for broad-spectrum antivirals during pandemics like COVID-19. Enmozhi et al. (2020) showed in silico inhibition of SARS-CoV-2 main protease, supporting repurposing for acute respiratory infections. Sa-ngiamsuntorn et al. (2021) confirmed anti-SARS-CoV-2 activity in human lung cells, highlighting potential as adjuvant therapy (Silveira et al., 2020). These properties address gaps in antiviral development amid rising viral threats.
Key Research Challenges
Translating in silico predictions
In silico docking by Enmozhi et al. (2020) and Murugan et al. (2020) predicts strong SARS-CoV-2 protease binding, but lacks clinical validation. Discrepancies arise between computational affinity scores and cellular efficacy. Experimental confirmation via plaque assays remains limited to select viruses.
Cytotoxicity in organ cells
Sa-ngiamsuntorn et al. (2021) evaluated andrographolide cytotoxicity in lung and major organ cells, revealing dose-dependent toxicity. Balancing antiviral potency with safety profiles challenges therapeutic dosing. Few studies assess long-term effects in vivo.
Broad-spectrum validation
Papers like Rajagopal et al. (2020) screen against COVID-19 but overlook other viruses like influenza. Limited plaque assay data hinders claims of broad activity. Synergy with existing drugs requires further combinatorial testing (Silveira et al., 2020).
Essential Papers
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine et al. · 2020 · Journal of Biomolecular Structure and Dynamics · 397 citations
SARS-CoV-2 virus which caused the global pandemic the Coronavirus Disease- 2019 (COVID-2019) has infected about 1,203,959 patients and brought forth death rate about 64,788 among 206 countries as m...
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
Dâmaris Silveira, Jose Maria Prieto-Garcia, Fábio Boylan et al. · 2020 · Frontiers in Pharmacology · 268 citations
Our work suggests that several herbal medicines have safety margins superior to those of reference drugs and enough levels of evidence to start a clinical discussion about their potential use as ad...
Anti-SARS-CoV-2 Activity of <i>Andrographis paniculata</i> Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives
Khanit Sa‐ngiamsuntorn, Ampa Suksatu, Yongyut Pewkliang et al. · 2021 · Journal of Natural Products · 184 citations
The coronaviruses disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) has become a major health problem, affecting more than 50 million people with over one million deaths globally. ...
Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach
Kalirajan Rajagopal, Potlapati Varakumar, Aparma Baliwada et al. · 2020 · Future Journal of Pharmaceutical Sciences · 128 citations
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19
Aditi Banerjee, Steven J. Czinn, Rüssel J. Reiter et al. · 2020 · Life Sciences · 120 citations
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
Dan Zhang, Bing Zhang, Jintao Lv et al. · 2020 · Pharmacological Research · 110 citations
Computational investigation on <i>Andrographis paniculata</i> phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials
N. Arul Murugan, Chitra Jeyaraj Pandian, Jeyaraman Jeyakanthan · 2020 · Journal of Biomolecular Structure and Dynamics · 107 citations
The outbreak due to SARS-CoV-2 (or Covid-19) is spreading alarmingly and number of deaths due to infection is aggressively increasing every day. Due to the rapid human to human transmission of Covi...
Reading Guide
Foundational Papers
No pre-2015 foundational papers available; start with Enmozhi et al. (2020) for baseline in silico SARS-CoV-2 inhibition and Silveira et al. (2020) for clinical context.
Recent Advances
Sa-ngiamsuntorn et al. (2021) for in vitro lung cell validation; Li et al. (2022) updates anti-inflammatory synergies aiding antiviral effects.
Core Methods
Molecular docking (AutoDock in Enmozhi et al., 2020), plaque reduction assays (Sa-ngiamsuntorn et al., 2021), cytotoxicity MTT assays across organ cells.
How PapersFlow Helps You Research Andrographolide Antiviral Properties
Discover & Search
PapersFlow's Research Agent uses searchPapers and exaSearch to find key works like Enmozhi et al. (2020) on SARS-CoV-2 protease inhibition, then citationGraph reveals 397 citing papers and findSimilarPapers uncovers related docking studies by Murugan et al. (2020).
Analyze & Verify
Analysis Agent employs readPaperContent on Sa-ngiamsuntorn et al. (2021) to extract plaque assay IC50 values, verifies claims with CoVe against raw data, and runs PythonAnalysis for statistical comparison of docking scores across Enmozhi et al. (2020) and Rajagopal et al. (2020) using pandas for binding energy distributions; GRADE grading scores evidence as moderate for in vitro antiviral activity.
Synthesize & Write
Synthesis Agent detects gaps like absent in vivo data post-Enmozhi et al. (2020), flags contradictions in cytotoxicity reports, and exports Mermaid diagrams of andrographolide-protease interactions; Writing Agent applies latexEditText to draft methods sections, latexSyncCitations for 10+ references, and latexCompile for publication-ready antiviral review manuscripts.
Use Cases
"Extract and plot docking scores of andrographolide vs known inhibitors from Enmozhi 2020 and Murugan 2020."
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas/matplotlib plots binding affinities) → researcher gets CSV of scores and visualized comparison graph.
"Write LaTeX review on andrographolide SARS-CoV-2 inhibition citing top 5 papers."
Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → researcher gets compiled PDF with diagrams via exportMermaid.
"Find code for andrographolide docking simulations from related papers."
Research Agent → findSimilarPapers (docking studies) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated AutoDock scripts and replication notebooks.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'andrographolide SARS-CoV-2', structures antiviral evidence into GRADE-scored report with citationGraph clusters. DeepScan applies 7-step CoVe to verify Enmozhi et al. (2020) docking claims against Sa-ngiamsuntorn et al. (2021) assays. Theorizer generates hypotheses on ER stress modulation from Banerjee et al. (2020) for novel antiviral targets.
Frequently Asked Questions
What defines andrographolide antiviral properties?
Inhibition of viral proteases like SARS-CoV-2 main protease via docking and plaque reduction in lung cells, as in Enmozhi et al. (2020) and Sa-ngiamsuntorn et al. (2021).
What methods assess these properties?
In silico molecular docking for binding prediction (Enmozhi et al., 2020; Murugan et al., 2020) and in vitro plaque assays in human lung epithelial cells (Sa-ngiamsuntorn et al., 2021).
What are key papers?
Enmozhi et al. (2020, 397 citations) on SARS-CoV-2 protease docking; Sa-ngiamsuntorn et al. (2021, 184 citations) on lung cell activity; Silveira et al. (2020, 268 citations) on adjuvant use.
What open problems exist?
Lack of clinical trials, in vivo efficacy beyond cells, and broad-virus testing; cytotoxicity optimization needed per Sa-ngiamsuntorn et al. (2021).
Research Andrographolide Research and Applications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Andrographolide Antiviral Properties with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers